RS5792235 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (14)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Phosphatidylcholine (18:0_20:4) levels | C | OR: 0.65 | 1E-126 | PubMed |
| Sterol ester (27:1/20:4) levels | C | OR: 0.64 | 7E-122 | PubMed |
| Phosphatidylcholine (O-16:0_20:4) levels | C | OR: 0.38 | 4E-115 | PubMed |
| Eicosapentaenoate (EPA; 20:5n3) levels | — | OR: 0.23 | 4E-104 | PubMed |
| Phosphatidylcholine (18:1_20:4) levels | C | OR: 0.49 | 2E-69 | PubMed |
| Phosphatidylcholine (O-16:1_20:4) levels | C | OR: 0.42 | 9E-44 | PubMed |
| Serum metabolite levels | CA | OR: 0.32 | 5E-41 | PubMed |
| Adrenate (22:4n6) levels | — | OR: 0.14 | 4E-30 | PubMed |
| Phosphatidylinositol (18:0_18:2) levels | C | OR: 0.28 | 1E-22 | PubMed |
| Serum metabolite ratios in chronic kidney disease | C | OR: 0.34 | 9E-15 | PubMed |
| Procollagen C-endopeptidase enhancer 1 levels | — | β: 0.099 | 3E-12 | PubMed |
| Metabolite levels (1-docosapentaenoylglycerophosphocholine (22:5n3)) | C | OR: 0.22 | 2E-11 | PubMed |
| Serum metabolite concentrations in chronic kidney disease | C | OR: 0.24 | 2E-8 | PubMed |
| Phosphatidylcholine (O-18:2_20:4) levels | C | OR: 0.17 | 2E-8 | PubMed |